Related Experiment Video
Updated: Dec 8, 2025

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
Published on: February 11, 2014
Validation of a Vision-Guided Mobility Assessment for RPE65-Associated Retinal Dystrophy
Neruban Kumaran1,2,3, Robin R Ali1,4, Nick A Tyler5
1UCL Institute of Ophthalmology, University College London, London, UK.
A new vision-guided mobility assessment effectively distinguishes individuals with RPE65-associated retinal dystrophy (RPE65-RD) from normally-sighted controls. This repeatable and valid tool is sensitive to low illumination, offering a crucial outcome measure for RPE65-RD.
Area of Science:
- Ophthalmology
- Neurology
- Human Movement Science
Background:
- RPE65-associated retinal dystrophy (RPE65-RD) significantly impacts vision and mobility.
- Validated assessments are crucial for tracking disease progression and treatment efficacy in RPE65-RD.
Purpose of the Study:
- To validate a novel vision-guided mobility assessment for individuals with RPE65-RD.
- To establish the repeatability, convergent, discriminant, and criterion validity of the assessment.
Main Methods:
- A comparative cross-sectional study involving 29 subjects (19 with RPE65-RD, 10 controls).
- Mobility was assessed via straight-line following, maze navigation, and obstacle stepping.
- Performance metrics included time, errors, and walking speed under varying illumination.
Main Results:
- Walking speed during maze navigation effectively discriminated between RPE65-RD and control groups (convergent and discriminant validity).
- Mobility was significantly poorer in RPE65-RD subjects under low illumination.
- The assessment demonstrated good repeatability and approached criterion validity.
Conclusions:
- A novel, quantifiable, and repeatable vision-guided mobility assessment was developed and validated for RPE65-RD.
- This assessment is sensitive to visual impairment in low light and captures phenotypic heterogeneity.
- It serves as a valuable outcome measure for RPE65-RD research and clinical trials.
More Related Videos
07:12Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
Published on: April 11, 2025
06:25Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
Published on: February 23, 2024